BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/30/2021 8:21:52 AM | Browse: 283 | Download: 422
 |
Received |
|
2021-06-07 01:06 |
|
Peer-Review Started |
|
2021-06-07 01:11 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-09-01 10:17 |
|
Revised |
|
2021-09-16 16:31 |
|
Second Decision |
|
2021-11-26 03:32 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-11-28 07:34 |
|
Articles in Press |
|
2021-11-28 07:34 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-11-07 10:17 |
|
Typeset the Manuscript |
|
2021-12-24 09:03 |
|
Publish the Manuscript Online |
|
2021-12-30 08:21 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Minireviews |
| Article Title |
Hepatitis B virus reactivation in rheumatoid arthritis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ya-Li Wu, Jing Ke, Bao-Yu Zhang and Dong Zhao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dong Zhao, MD, PhD, Associate Professor, Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, No. 82 Xinhua South Road, Tongzhou District, Beijing 101149, China. zhaodong@ccmu.edu.cn |
| Key Words |
Rheumatoid arthritis; Hepatitis B virus reactivation; Disease-modifying antirheumatic drugs; Risk factors |
| Core Tip |
The application of anti-viral drugs and anti-rheumatic drugs improves the prognosis of patients with hepatitis B virus (HBV) infection and rheumatoid arthritis (RA). However, the reactivation of HBV in RA patients has not attracted enough attention. Although the HBV infection rate in RA patients is not high, once HBV reactivation (HBVr) occurs, it will cause serious consequences. Therefore, patients with HBV infection should undergo comprehensive evaluation before anti-rheumatic drug treatment. This paper summarizes the mechanism of HBVr, the risk of HBVr caused by anti-rheumatic drugs, and the appropriate diagnosis and treatment process for RA patients. |
| Publish Date |
2021-12-30 08:21 |
| Citation |
Wu YL, Ke J, Zhang BY, Zhao D. Hepatitis B virus reactivation in rheumatoid arthritis. World J Clin Cases 2022; 10(1): 12-22 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i1/12.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i1.12 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
